| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a transdermal absorption type additive agent which prevents a nonsteroidal analgesic/antiphlogistic agent having a carboxyl group in a molecule and I-menthol from being esterified, and exhibits a favorable analgesic effect. <P>SOLUTION: The transdermal absorption type additive agent 1a has a support base 10a, and a first medicine containing part 11a and a second medicine containing part 12a which are formed on the support base 10 and contain medicines. The first medicine containing part 11a contains the nonsteroidal analgesic/antiphlogistic agent having the carboxyl group in the molecule, and the second medicine containing part 12a contains the I-menthol and does not substantially contain the nonsteroidal analgesic/antiphlogistic agent. It is preferable that the nonsteroidal analgesic/antiphlogistic agent is felbinac. A transdermal absorption progressing agent for progressing the absorption of the medicine into a skin is contained in the first medicine containing part 11a. An interval 13a as a prohibition tool for prohibiting the transition of the medicine is formed between the first medicine containing part 11a and the second medicine containing part 12a. <P>COPYRIGHT: (C)2013,JPO&INPIT |
